JENNIFER BANNER: Open Payments
NPI 1043590763 · TRENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 8 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $317 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $97 |
| Amgen Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| ConvaTec Inc. | 1 | $14 |
Products named: Wegovy, REBLOZYL, Rybelsus, OTEZLA, LYBALVI, TRELEGY ELLIPTA, Cologuard Collection Kit, INNOVAMATRIX AC.
Industry payments across FL — which companies pay providers there.
